Characteristics of aggressive variants in T1a renal cell carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 11, 2011, Pages 1653-1659

  Takayama, Tatsuya ^a   Sugiyama, Takayuki ^a   Kai, Fumitake ^a   Suzuki, Takahisa ^a   Nagata, Masahiro ^a   Imanishi, Takeshi ^b   Mizuno, Takuji ^c   Sato, Shigenori ^d   Furuse, Hiroshi ^a   Mugiya, Soichi ^a   Ozono, Seiichiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJIEDA MUNICIPAL GENERAL HOSPITAL   (Japan)

^c Iwata City Hospital   (Japan)

^d University of Tokyo   (Japan)

Author keywords

CRP; Metastasis; Renal cell carcinoma; Sarcomatoid; Symptomatic; T1a

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER GRADING; CANCER INCIDENCE; CANCER INVASION; CANCER MORPHOLOGY; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATHOLOGY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 80054767970     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1040-y     Document Type: Article

References (27)

1. SC Campbell AC Novick A Belldegrun ML Blute GK Chow IH Derweesh, et al. 2009 Guideline for management of the clinical T1 renal mass J Urol 182 1271 1279 19683266 10.1016/j.juro.2009.07.004
2. JC Cheville CM Lohse H Zincke AL Weaver BC Leibovich I Frank, et al. 2004 Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome Am J Surg Pathol 28 435 441 15087662 10.1097/00000478-200404000-00002 (Pubitemid 38436516)
3. WH Chow SS Devesa JL Warren JF Fraumeni Jr 1999 Rising incidence of renal cell carcinoma in the United States JAMA 281 1628 1631 10235157 10.1001/jama.281.17.1628 1:STN:280:DyaK1M3kvFagtA%3D%3D (Pubitemid 29211773)
4. PL Crispen R Viterbo EB Fox RE Greenberg DY Chen RG Uzzo 2008 Delayed intervention of sporadic renal masses undergoing active surveillance Cancer 112 1051 1057 18286513 10.1002/cncr.23268 (Pubitemid 351304589)
5. M de Peralta-Venturina H Moch M Amin P Tamboli S Hailemariam M Mihatsch, et al. 2001 Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases Am J Surg Pathol 25 275 284 11224597 10.1097/00000478-200103000-00001 (Pubitemid 32174196)
6. PD Gonçalves M Srougi MF Dall'lio KR Leite V Ortiz F Hering 2004 Low clinical stage renal cell carcinoma: relevance of microvascular tumor invasion as a prognostic parameter J Urol 172 470 474 15247705 10.1097/01.ju.0000130582.31467.30 (Pubitemid 38900179)
7. Y Homma K Kawabe T Kitamura Y Nishimura M Shinohara Y Kondo I Saito, et al. 1995 Increased incidental detection and reduced mortality in renal cancer-recent retrospective analysis at eight institutions Int J Urol 2 77 80 7553292 10.1111/j.1442-2042.1995.tb00428.x 1:STN:280:DyaK28%2FlsF2jsA%3D%3D
8. RM Hsu DY Chan SS Siegelmann 2004 Small renal cell carcinomas: correlation of size with tumor stage, nuclear grade, and histologic subtype AJR Am J Roentgenol 182 551 557 14975944 (Pubitemid 38269508)
9. WC Huang AS Levey AM Serio M Snyder AJ Vickers GV Raj, et al. 2006 Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study Lancet Oncol 7 735 740 16945768 10.1016/S1470-2045(06)70803-8 (Pubitemid 44283660)
10. K Ito T Asano H Yoshii A Satoh M Sumitomo M Hayakawa 2006 Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma Int J Urol 13 1365 1370 17083384 10.1111/j.1442-2042. 2006.01563.x 1:CAS:528:DC%2BD28XhtlensLnI (Pubitemid 44657040)
11. SP Jagdev W Gregory NS Vasudev P Harnden S Sim D Thompson, et al. 2010 Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein Br J Cancer 103 1649 1656 21063409 10.1038/sj.bjc.6605973 1:CAS:528:DC%2BC3cXhsVygsrrJ
12. P Jain R Surdas P Aga M Jain R Kapoor A Srivastava, et al. 2009 Renal cell carcinoma: impact of mode of detection on its pathological characteristics Indian J Urol 25 479 482 19955672 10.4103/0970-1591.57919
13. TV Johnson A Abbasi A Owen-Smith A Young K Ogan J Pattaras, et al. 2010 Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma J Urol 183 480 485 20006861 10.1016/j.juro.2009.10.014 1:CAS:528:DC%2BC3cXitVSrt7s%3D
14. Johnson TV, Abbasi A, Owen-Smith A, Young AN, Kucuk O, Harris WB, Osunkoya AO, Ogan K, Pattaras J, Nieh PT, Marshall FF, Master VA (2010b) Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma. Urology 76:766.e1-e5 (epub 2010 Apr 14)
15. Y Kitagawa K Nakashima T Shima K Izumi K Narimoto S Miwa, et al. 2011 Clinicopathological outcomes of clinical T1a renal cell carcinoma by tumor size Jpn J Clin Oncol 41 637 641 21297120 10.1093/jjco/hyr007
16. T Klatte JJ Patard M de Martino K Bensalah G Verhoest A de la Taille, et al. 2008 Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas J Urol 179 1719 1726 18343437 10.1016/j.juro.2008. 01.018
17. Y Komai K Saito K Sakai S Morimoto 2007 Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma BJU Int 99 77 80 16956357 10.1111/j.1464-410X.2006.06497.x 1:CAS:528:DC%2BD2sXhtlSjsbk%3D (Pubitemid 44915624)
18. H Kume M Suzuki T Fujimura H Fukuhara Y Enomoto H Nishimatsu, et al. 2010 Distant metastasis of renal cell carcinoma with a diameter of 3 cm or less-which is aggressive cancer? J Urol 184 64 68 20478591 10.1016/j.juro.2010. 03.019
19. CT Lee J Katz PA Fearn P Russo 2002 Mode of presentation of renal cell carcinoma provides prognostic information Urol Oncol 7 135 140 12474528 10.1016/S1078-1439(01)00185-5
20. G Lughezzani C Jeldres H Isbarn P Perrotte SF Shariat M Sun, et al. 2009 Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis J Urol 182 1287 1293 19683281 10.1016/j.juro.2009.06.018
21. S Naito N Yamamoto T Takayama M Muramoto N Shinohara K Nishiyama, et al. 2010 Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients Eur Urol 57 317 3125 19136199 10.1016/j.eururo.2008.12.026 1:CAS:528:DC%2BC3cXls12ktLg%3D
22. T Nishikimi T Tsuzuki T Fujita N Sassa A Fukatsu S Katsuno, et al. 2011 The post-operative pathological prognostic parameters of clear cell renal cell carcinoma in pT1a cases Pathol Int 61 116 121 21355952 10.1111/j.1440-1827.2010. 02633.x
23. JJ Patard A Rodriguez N Rioux-Leclercq F Guillé B Lobel 2002 Prognostic significance of the mode of detection in renal tumours BJU Int 90 358 363 12175389 10.1046/j.1464-410X.2002.02910.x (Pubitemid 36124764)
24. F Porpiglia A Volpe M Billia RM Scarpa 2008 Laparoscopic versus open partial nephrectomy: analysis of the current literature Eur Urol 53 732 742 18222599 10.1016/j.eururo.2008.01.025 discussion 742-743
25. Sobin LH, Gospodarowicz M, Wittekind C (eds) (2009) TNM classification of malignant tumours, 7th edn. Wiley-Blackwell, New York
26. The Japanese Urological Association, The Japanese Pathological Society, The Japan Radiological Society (2011) General rules for clinical and pathological studies on renal cell carcinoma, 4th edn. Kanehara & Co, Tokyo
27. H Wunderlich O Reichelt S Schumann A Schlichter H Kosmehl W Werner, et al. 1998 Nephron sparing surgery for renal cell carcinoma 4 cm. or less in diameter: indicated or under treated? J Urol 159 1465 1469 9554334 10.1097/00005392-199805000-00012 1:STN:280:DyaK1c3ht12qtA%3D%3D (Pubitemid 29117321)